Abstract
Since Kramer’s initial description of the procedure he called continuous arteriovenous hemofiltration (CAVH) (1), its role in the management of acute renal failure has been considerably expanded (2–4). Because most patients undergoing CAVH are critically ill, optimal management of concurrent medications is a necessity. Only recently has drug handling during CAVH been studied in any detail (4–8). It is the purpose of this chapter to review the factors related to drug handling during CAVH, to establish uniform terminology and methodology for drug data collection, to summarize the available data concerning specific drugs, and to recommend an approach to drug administration in patients undergoing CAVH.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kramer P, Wigger W. Rieger J, et al: Arteriovenous hemofiltration: a new and simple method for treatment of overhydrated patients resistant to diuretics. Klin Wochenschr 55:1121–2, 1977.
Golper TA: Continuous arteriovenous hemofiltration in acute renal failure. Am J Kid Dis 1985 (In press).
Kaplan AA, Longnecker RE, Folkert VW: Continuous arteriovenous hemofiltration. Ann Intern Med 100:358–367, 1984.
Paganini EP, O’Hara P, Nakamoto S: Slow continuous Ultrafiltration in hemodialysis resistant oliguric acute renal failure patients. Trans Am Soc Artif Intern Organs 30:173–177, 1984.
Kaplan AA, Longnecker RE, Folkert VW: Continuous hemofiltration: in response (Letters). Ann Intern Med 101:145–146, 1984.
Ossenkopple GJ, Van der Muellen J, Bronsveld W, et al: Continuous arteriovenous hemofiltration as an adjunctive therapy for septic shock. Crit Care Med 13:102–104, 1985.
Golper TA, Pulliam J, Bennett WM: Removal of therapeutic drugs by continuous arteriovenous hemofiltration. Arch Intern Med 145:1651–1652, 1985.
Golper TA, Wedel SK, Kaplan AA, Saad A-M, Donta ST, Paganini EP: Drug removal during continuous arteriovenous hemofiltration: theory and clinical observations. Intern J Artif Organs 1985 (In press).
Colton CK, Henderson LW, Ford CA, et al: Kinetics of hemodiafiltration. I. In vitro transport characteristics of a hollow fiber blood ultrafilter. J Lab Clin Med 85:355–371, 1975.
Leypoldt JK, Frigon RP, Henderson LW: Dextran sieving coefficients of hemofilter membranes. Trans Am Soc Artif Intern Organs 29:678–683, 1983.
Frigon RP, Leypoldt JK, Alford MF, et al: Hemofilter solute sieving is not governed by dynamically polarized protein. Ibid. 486–490, 1984.
Golper TA, Saad A-M: Gentamicin and phenytoin in vitro sieving characteristics through polysulfone hemofilters: effect of flow rate, drug concentration, and solvent hemofilters: effect of flow rate, drug concentration, and solvent systems (submitted for review).
Reidenberg MM, Affrime M: Influence of disease on binding of drugs to plasma protein. Ann NY Acad Sci 226:115–126, 1973.
Dayton PG, Israili ZH, Perel JM: Influence of binding on drug metabolism and distribution. Ibid. 226:172–194, 1973.
Anton AH: Increasing activity of sulfonamides with displacing agents. Ibid. 226:273–292, 1973.
Reidenberg MM: The binding of drugs to plasma protein and the interpretation of measurements of plasma concentration of drugs in patients with poor renal function. Am J Med 62:460–470, 1977.
Tillement JP, Lhoste F, Fiudicelli TF: Diseases and drug protein binding. Clin Pharmacokin 3:144–154, 1978.
McNamara PJ, Lalka D, Gibaldi M: Endogenous accumulation products and serum protein binding in uremia. J Lab Clin Med 98:740, 1981.
Gulyassy PF, Depner TA: Impaired binding of drugs and endogenous ligands in renal disease. Am J Kid Dis 2:578–601, 1983.
Keller F, Wilms H, Schulte G, et al: Effect of plasma protein binding, volume of distribution and molecular weight on the fraction of drugs eliminated by hemodi-alysis. Clin Nephrol 19:201–205, 1983.
Suh B, Craig WA, England AC, et al: Effect of the free fatty acids on protein binding of antimicrobial agents. J Infect Dis 143:609–616.
Kraft D, Lode H: Elimination of ampicillin and genta-micin by hemofiltration. Klin Wochenschr 57:195–196, 1979.
Klein E, Holland FF, Eberle K: Rejection of solutes by hemofiltration membranes. ASAIO J 1:15–23, 1978.
Rockel A, Gilge U, Liewald A, et al: Elimination of low molecular weight proteins during hemofiltration. Artif Organs 6:307–311, 1982.
Michaels AS: Analysis and prediction of sieving curves for ultrafiltration membranes: a universal correlation? Separation Sci and Tech 15:1305–1322, 1980.
Feldhoff P, Tunham T, Klein E: Effect of plasma proteins on the sieving spectra of hemofilters. Artif Organs 8:186–192, 1984.
Jaffrin MY, Vantard G, Granger A: A concentration polarization model of hemofiltration with highly permeable membranes. ASAIO J 2:73–85, 1985.
Dodd NJ, O’Donovan RM, Bennett-Jones DN: Arteriovenous haemofiltration: a recent advance in the management of renal failure. Br Med J 287:1008–1010, 1983.
Pauls A, Grigoleit H-G, Von Herrath D, Schaefer K: Comparison of drug elimination by current methods of blood purification. Blood Purification 2:14–22, 1984.
Zarowitz BJM, Anandan JV, Jayashankar J, et al: Ultra-filtration clearance of aminoglycoside antibiotics. Drug Intell Clin Pharm 19:459, 1985.
Lauer A, Saccaggi A, Ronco C, et al: Continuous arteriovenous hemofiltration in the critically ill patient. Ann Intern Med 99:455–460, 1983.
Bennett WM, Aronoff GR, Morrison G, et al: Drug prescribing in renal failure: dosing guidelines for adults. Am J Kid Dis 3:155–193, 1983.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Martinus Nijhoff Publishing
About this chapter
Cite this chapter
Golper, T. (1986). Drug Kinetics and Continuous Arteriovenous Hemofiltration. In: Paganini, E.P. (eds) Acute Continuous Renal Replacement Therapy. Developments in Nephrology, vol 13. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2311-2_11
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2311-2_11
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9422-1
Online ISBN: 978-1-4613-2311-2
eBook Packages: Springer Book Archive